Identification of Susceptible Genes for Chronic Obstructive Pulmonary Disease with Lung Adenocarcinoma by Weighted Gene Co-Expression Network Analysis

References

• Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc. 2014;11(3):404–406. doi:10.1513/AnnalsATS.201311-405PS
   PubMedGoogle Scholar
• Wang W, Xie M, Dou S, et al. The link between chronic obstructive pulmonary disease phenotypes and histological subtypes of lung cancer: a case-control study. Int J Chron Obstruct Pulmon Dis. 2018;13:1167–1175. doi:10.2147/COPD.S158818
   PubMed Web of Science ®Google Scholar
• Zamarron E, Prats E, Tejero E, et al. Static lung hyperinflation is an independent risk factor for lung cancer in patients with chronic obstructive pulmonary disease. Lung Cancer. 2019;128:40–46. doi:10.1016/j.lungcan.2018.12.012
   PubMed Web of Science ®Google Scholar
• Husebo GR, Nielsen R, Hardie J, et al. Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study. Respir Med. 2019;152:81–88. doi:10.1016/j.rmed.2019.04.019
   PubMed Web of Science ®Google Scholar
• Young RP, Duan F, Chiles C, et al. Airflow limitation and histology shift in the national lung screening Trial. The NLST-ACRIN Cohort Substudy. Am J Respir Crit Care Med. 2015;192(9):1060–1067. doi:10.1164/rccm.201505-0894OC
   PubMed Web of Science ®Google Scholar
• Carr LL, Jacobson S, Lynch DA, et al. Features of COPD as predictors of lung cancer. Chest. 2018;153(6):1326–1335. doi:10.1016/j.chest.2018.01.049
   PubMed Web of Science ®Google Scholar
• Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur Respir J. 2009;34(2):380–386. doi:10.1183/09031936.00144208
   PubMed Web of Science ®Google Scholar
• Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178(7):738–744. doi:10.1164/rccm.200803-435OC
   PubMed Web of Science ®Google Scholar
• Durham AL, Adcock IM. The relationship between COPD and lung cancer. Lung Cancer. 2015;90(2):121–127. doi:10.1016/j.lungcan.2015.08.017
   PubMed Web of Science ®Google Scholar
• Houghton AM. Mechanistic links between COPD and lung cancer. Nat Rev Cancer. 2013;13(4):233–245. doi:10.1038/nrc3477
   PubMed Web of Science ®Google Scholar
• Caramori G, Ruggeri P, Mumby S, et al. Molecular links between COPD and lung cancer: new targets for drug discovery? Expert Opin Ther Targets. 2019;23(6):539–553. doi:10.1080/14728222.2019.1615884
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang H, Pan T, Wang H, Wang Y. Benzo(a)pyrene promotes migration, invasion and metastasis of lung adenocarcinoma cells by upregulating TGIF. Toxicol Lett. 2018;294:11–19. doi:10.1016/j.toxlet.2018.05.005
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Radulescu E, Jaffe AE, Straub RE, et al. Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain. Mol Psychiatry. 2018;25(4):791–804. doi:10.1038/s41380-018-0304-1
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. Fast R functions for robust correlations and hierarchical clustering. J Stat Softw. 2012;46(11):11. doi:10.18637/jss.v046.i11
   Web of Science ®Google Scholar
• Botia JA, Vandrovcova J, Forabosco P, et al. An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol. 2017;11(1):47. doi:10.1186/s12918-017-0420-6
   PubMed Web of Science ®Google Scholar
• Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362–d368. doi:10.1093/nar/gkw937
   PubMed Web of Science ®Google Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Zhao S, Wang X, Li N, et al. Effects of strontium ranelate on bone formation in the mid-palatal suture after rapid maxillary expansion. Drug Des Devel Ther. 2015;9:2725–2734. doi:10.2147/DDDT.S82892
   PubMed Web of Science ®Google Scholar
• Guo L, Wang T, Wu Y, et al. WNT/beta-catenin signaling regulates cigarette smoke-induced airway inflammation via the PPARdelta/p38 pathway. Lab Invest. 2016;96(2):218–229. doi:10.1038/labinvest.2015.101
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen D, Qiu X, et al. Relationship between MTA1 and spread through air space and their joint influence on prognosis of patients with stage I-III lung adenocarcinoma. Lung Cancer. 2018;124:211–218. doi:10.1016/j.lungcan.2018.07.040
   PubMed Web of Science ®Google Scholar
• Sen N, Gui B, Kumar R. Role of MTA1 in cancer progression and metastasis. Cancer Metastasis Rev. 2014;33(4):879–889. doi:10.1007/s10555-014-9515-3
   PubMed Web of Science ®Google Scholar
• Liu L, Wu J, Wang S, et al. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/TCF signaling. Exp Cell Res. 2017;358(2):209–216. doi:10.1016/j.yexcr.2017.06.014
   PubMed Web of Science ®Google Scholar
• Sun QS, Luo M, Zhao HM, Sun H. Overexpression of PKMYT1 indicates the poor prognosis and enhances proliferation and tumorigenesis in non-small cell lung cancer via activation of Notch signal pathway. Eur Rev Med Pharmacol Sci. 2019;23(10):4210–4219. doi:10.26355/eurrev_201905_17925
   PubMed Web of Science ®Google Scholar
• Li DQ, Divijendra Natha Reddy S, Pakala SB, et al. MTA1 coregulator regulates p53 stability and function. J Biol Chem. 2009;284(50):34545–34552. doi:10.1074/jbc.M109.056499
   PubMed Web of Science ®Google Scholar
• Rohe A, Erdmann F, Bassler C, et al. In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase. Bioorg Med Chem Lett. 2012;22(2):1219–1223. doi:10.1016/j.bmcl.2011.11.064
   PubMed Web of Science ®Google Scholar
• Eguren M, Manchado E, Malumbres M. Non-mitotic functions of the Anaphase-Promoting Complex. Semin Cell Dev Biol. 2011;22(6):572–578. doi:10.1016/j.semcdb.2011.03.010
   PubMed Web of Science ®Google Scholar
• Sorensen CS, Lukas C, Kramer ER, et al. Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol Cell Biol. 2000;20(20):7613–7623. doi:10.1128/MCB.20.20.7613-7623.2000
   PubMed Web of Science ®Google Scholar
• Garcia-Higuera I, Manchado E, Dubus P, et al. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat Cell Biol. 2008;10(7):802–811. doi:10.1038/ncb1742
   PubMed Web of Science ®Google Scholar
• Lafranchi L, De Boer HR, De Vries EGE, et al. APC/CCdh1 controls CtIP stability during the cell cycle and in response to DNA damage. EMBO J. 2014;33(23):2860–2879. doi:10.15252/embj.201489017
   PubMed Web of Science ®Google Scholar
• Wan L, Chen M, Cao J, et al. The APC/C E3 ligase complex activator FZR1 restricts BRAF oncogenic function. Cancer Discov. 2017;7(4):424–441. doi:10.1158/2159-8290.CD-16-0647
   PubMed Web of Science ®Google Scholar
• Lehman NL, Tibshirani R, Hsu JY, et al. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am J Pathol. 2007;170(5):1793–1805. doi:10.2353/ajpath.2007.060767
   PubMed Web of Science ®Google Scholar
• Crawford LJ, Anderson G, Johnston CK, Irvine AE. Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma. Oncotarget. 2016;7(43):70481–70493. doi:10.18632/oncotarget.12026
   PubMedGoogle Scholar